Mabthera and febrile neutropenia Patient Reports February 12, 2012

Mabthera Side Effects Report #5592378-0
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Jan 04, 2008. Female patient, 79 years of age, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, pseudomonal sepsis. Mabthera dosage: unknown. During the same period patient was treated with MOPRAL, SPIRONOLACTONE, SPECIAFOLDINE, METHOTREXATE, POTASSIUM CHLORIDE, PREVISCAN, CORDARONE, TETRAZEPAM. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5513554-9
Mabthera side effect was reported by a Physician from FRANCE on Nov 12, 2007. Male patient, 50 years of age, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, pharyngitis streptococcal. Mabthera dosage: unknown. During the same period patient was treated with METHOTREXATE, SPECIAFOLDINE, CORTICOIDS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5609318-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Jan 21, 2008. Female patient was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, pseudomonal sepsis. Mabthera dosage: unknown. During the same period patient was treated with MOPRAL, SPIRONOLACTONE, SPECIAFOLDINE, METHOTREXATE, POTASSIUM CHLORIDE, PREVISCAN, CORDARONE, TETRAZEPAM. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5930209-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Oct 09, 2008. Female patient was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aphthous stomatitis, febrile neutropenia, gingivitis. Mabthera dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLICIL, PREDNISOLONE, CALCIUM, ASPIRIN, PLAQUENIL, FOSAMAX, ZARATOR. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4625799-0
Mabthera side effect was reported by a Physician from on Mar 18, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased, white blood cell count increased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4704615-2
Mabthera side effect was reported by a Health Professional from on June 20, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON, RULIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4712847-2
Mabthera side effect was reported by a Physician from AUSTRALIA on June 20, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haemoglobin decreased, white blood cell count decreased, white blood cell count increased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON, RULIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4977453-3
Mabthera side effect was reported by a Health Professional from GERMANY on Mar 31, 2006. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, febrile neutropenia, pancytopenia, pneumonia , respiratory failure, thrombocytopenia. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died on 09/30/2004.

Mabthera Side Effects Report #5298291-0
Mabthera side effect was reported by a Pharmacist from CANADA on Mar 29, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: colitis, febrile neutropenia. Mabthera dosage: 700 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #5835864-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on July 21, 2008. Male patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, pulmonary embolism . Mabthera dosage: 375 MG/M2, Q24H X 4D. During the same period patient was treated with MYOCET, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient died.

Mabthera Side Effects Report #4709489-1
Mabthera side effect was reported by a Physician from NETHERLANDS on June 23, 2005. Female patient, 69 years of age, weighting 145.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, urinary tract infection . Mabthera dosage: 675 MG,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5028023-2
Mabthera side effect was reported by a Health Professional from SPAIN on Apr 07, 2006. Female patient, 68 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. Mabthera dosage: 375 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE, NEORECORMON, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060296-2
Mabthera side effect was reported by a Physician from SPAIN on July 12, 2006. Female patient, 66 years of age, weighting 153.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, staphylococcal infection . Mabthera dosage: 375 MG/M2, Q3W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, SEPTRINTE, CITALOPRAM HYDROBROMIDE, ORPHOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5023686-X
Mabthera side effect was reported by a Physician from SPAIN on Mar 28, 2005. Female patient, 66 years of age, weighting 153.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 375 MG/M2, Q3W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4661255-1
Mabthera side effect was reported by a Physician from on May 02, 2005. Female patient, 65 years of age, weighting 112.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 690 MG,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4713417-2
Mabthera side effect was reported by a Physician from GERMANY on June 22, 2005. Female patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anal abscess, febrile neutropenia. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4714649-X
Mabthera side effect was reported by a Physician from CANADA on June 27, 2005. Female patient, 65 years of age, weighting 112.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, hyperglycaemia, mucosal inflammation. Mabthera dosage: 690 MG,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ANTIBIOTICS, TOPICAL ANALGESIC, ANTIFUNGAL AGENTS, INSULIN DRIP. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4562748-8
Mabthera side effect was reported by a Physician from on Jan 13, 2005. Male patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 840 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4707424-3
Mabthera side effect was reported by a Physician from UNITED KINGDOM on June 20, 2005. Male patient, 58 years of age, weighting 158.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, fall , febrile neutropenia, lower respiratory tract infection. Mabthera dosage: 712 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4600657-6
Mabthera side effect was reported by a Physician from on Feb 21, 2005. Male patient, 57 years of age, weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 800 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4654113-X
Mabthera side effect was reported by a Health Professional from on Apr 25, 2005. Male patient, 57 years of age, weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, malaise. Mabthera dosage: 800 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4659362-2
Mabthera side effect was reported by a Health Professional from on Apr 28, 2005. Male patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: back pain , disease progression, febrile neutropenia, intervertebral disc protrusion, lymphoma , multi-organ failure, pain in extremity, pancytopenia, sepsis . Mabthera dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with ZEVALIN, YTRACIS, FILGRASTIM, CEFTRIAXONE, CLINDAMYCIN HYDROCHLORIDE, LEVOFLOXACIN, FLUCONAZOLE. Patient died.

Mabthera Side Effects Report #4669461-7
Mabthera side effect was reported by a Health Professional from on May 12, 2005. Male patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-cell lymphoma stage iv, back pain , bone marrow disorder, febrile neutropenia, intervertebral disc protrusion, leukopenia, malignant neoplasm progression, multi-organ failure. Mabthera dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with ZEVALIN, YTRACIS, FILGRASTIM, CEFTRIAXONE, CLINDAMYCIN HYDROCHLORIDE, LEVOFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #4590096-9
Mabthera side effect was reported by a Physician from on Feb 05, 2005. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: erythropoiesis abnormal, febrile neutropenia, myeloid maturation arrest. Mabthera dosage: 650 MG, 1/WEEK, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4954459-1
Mabthera side effect was reported by a Physician from GERMANY on Mar 15, 2006. Male patient, 50 years of age, weighting 209.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 375 MG/M2, INTRAVENOUS. Patient recovered.

Mabthera Side Effects Report #4665036-4
Mabthera side effect was reported by a Physician from on May 09, 2005. Male patient, 48 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4685147-7
Mabthera side effect was reported by a Physician from on May 25, 2005. Female patient, 41 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4708950-3
Mabthera side effect was reported by a Physician from NORWAY on June 29, 2005. Female patient, 41 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4754430-9
Mabthera side effect was reported by a Physician from NORWAY on Aug 17, 2005. Female patient, 41 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4898554-4
Mabthera side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 18, 2006. Female patient, 33 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Mabthera dosage: 375 MG/M2,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #6138936-6
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Mar 16, 2009. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, LOPERAMIDE, METOCLOPRAMIDE, ESOMEPRAZOLE, SPASFON. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5884248-5
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2008. Male patient, 48 years of age, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: depressed level of consciousness, dysphagia, febrile neutropenia, respiratory disorder. Mabthera dosage: unknown. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, IFOSFAMIDE. Patient died.

Mabthera Side Effects Report #4750039-1
Mabthera side effect was reported by a Physician from FRANCE on Aug 09, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, CORTANCYL, ADRIABLASTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4754791-0
Mabthera side effect was reported by a Physician from FRANCE on Aug 16, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISONE, ADRIABLASTINE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #5052940-0
Mabthera side effect was reported by a Health Professional from SPAIN on June 29, 2006. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5029131-2
Mabthera side effect was reported by a Health Professional from SPAIN on Apr 21, 2005. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #5090705-4
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Aug 15, 2006. Male patient, 56 years of age, weighting 172.8 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MITOXANTRONE, CYCLOPHOSPHAMIDE, FLUCONAZOLE, SEPTIN, CHLORHEXIDINE MOUTHWASH. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5028020-7
Mabthera side effect was reported by a Health Professional from SPAIN on May 08, 2006. Male patient, 48 years of age, weighting 220.5 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 375 MG/M2, Q3X, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, KYTRIL, SOLU MODERIN, POLARAMINE, PROFENAL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5113393-7
Mabthera side effect was reported by a Physician from SPAIN on Sept 06, 2006. Male patient, 40 years of age, weighting 136.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 375 MG/ML, Q4W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ACYCLOVIR, PENTAMIDINE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4569734-2
Mabthera side effect was reported by a Physician from on Jan 18, 2005. Male patient, 37 years of age, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bacteria urine identified, c-reactive protein increased, febrile neutropenia, white blood cell count decreased. Mabthera dosage: 800 MG Q3W INTRAVENOUS. During the same period patient was treated with ROFERON, ACETAMINOPHEN, SUMATRIPTAN SUCCINATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5830511-3
Mabthera side effect was reported by a Physician from UNITED KINGDOM on July 17, 2008. Male patient was diagnosed with lymphoma , non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. During the same period patient was treated with ONCOVIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, CORTANCYL, TAHOR, VASTAREL, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, COSOPT. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5899244-1
Mabthera side effect was reported by a Physician from UNITED STATES on Sept 18, 2008. Male patient, weighting 142.2 lb, was diagnosed with lymphoma , anxiety  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia. Mabthera dosage: 375 MG/M2, Q2W. During the same period patient was treated with NEULASTA, OXALIPLATIN, GEMCITABINE, MESNA, IFOSFAMIDE, NOVANTRONE, ETOPOSIDE, ANTIANXIETY AGENT NOS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6086384-X
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Feb 05, 2009. Male patient was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 750 MG, UNK. During the same period patient was treated with CARDIOXANE, ENDOXAN, ONCOVIN, DOXORUBICIN, ZOPHREN, SOLUDECADRON, POLARAMINE, AZANTAC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5933194-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Oct 13, 2008. Male patient, 26 years of age, was diagnosed with graft versus host disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOSPORINE, METHOTREXATE, BUDESONIDE, PREDNISOLONE. Patient recovered.

Mabthera Side Effects Report #6005382-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 01, 2008. Female patient, 69 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: central nervous system lymphoma, febrile neutropenia, mucosal inflammation. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EPIRUBICIN, VINCRISTINE, PREDNISOLONE, METHOTREXATE, DEXAMETHASONE. Patient recovered.

Mabthera Side Effects Report #4685154-4
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, 69 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased. Mabthera dosage: 680 MG, Q14D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, NEXIUM, LOCOL, ALLOPURINOL, BELOC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4698359-3
Mabthera side effect was reported by a Physician from on June 07, 2005. Male patient, 69 years of age, weighting 154.3 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: catheter site infection, febrile neutropenia, klebsiella infection, sepsis . Mabthera dosage: 680 MG, Q14D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, NEXIUM, LOCOL, ALLOPURINOL, BELOC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5035191-5
Mabthera side effect was reported by a Physician from GERMANY on June 20, 2006. Male patient, 69 years of age, weighting 154.3 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: catheter related infection, febrile neutropenia, haemoglobin decreased, klebsiella infection, sepsis . Mabthera dosage: 680 MG, Q14D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEXIUM, LOCOL, ALLOPURINOL, BELOC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5281330-0
Mabthera side effect was reported by a Physician from SWITZERLAND on Mar 14, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, multi-organ failure, platelet count decreased, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 09/01/2005.


Mabthera Side Effects Report #4597205-6
Mabthera side effect was reported by a Physician from on Feb 15, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, respiratory tract infection. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4607432-7
Mabthera side effect was reported by a Physician from on Feb 24, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow depression, diarrhoea, febrile neutropenia, haemophilus infection, lung infection, sputum culture positive, streptococcal infection . Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4649841-6
Mabthera side effect was reported by a Physician from on Apr 18, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, haemoglobin decreased, humerus fracture, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, CYTARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4708955-2
Mabthera side effect was reported by a Physician from ISRAEL on June 22, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma, prophylaxis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow depression, diarrhoea, febrile neutropenia, haemophilus infection, lung infection, pneumonia streptococcal, sputum culture positive. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, MESNA. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4776604-3
Mabthera side effect was reported by a Health Professional from SWITZERLAND on Sept 05, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, infection , laboratory test interference, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4688477-8
Mabthera side effect was reported by a Consumer or non-health professional from on May 25, 2005. Male patient, 62 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4708945-X
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2005. Male patient, 62 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4776606-7
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Sept 07, 2005. Male patient, 62 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, unevaluable event. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4568352-X
Mabthera side effect was reported by a Physician from on Jan 18, 2005. Female patient, 53 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, dehydration, febrile neutropenia, haemoglobin decreased, nausea , platelet count decreased, renal impairment, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5030844-7
Mabthera side effect was reported by a Physician from AUSTRALIA on June 09, 2006. Male patient, 27 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #5526750-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 14, 2007. Male patient, weighting 113.5 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia . Mabthera dosage: 580 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5537991-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 27, 2007. Male patient, weighting 113.5 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia . Mabthera dosage: 580 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died on 07/23/2007.

Mabthera Side Effects Report #4777108-4
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Sept 01, 2005. Male patient, 78 years of age, weighting 145.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atrial fibrillation , dizziness , febrile neutropenia, haemoglobin decreased, hiatus hernia, lung hyperinflation, malaise. Mabthera dosage: 670 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, OXAZEPAM, ASPIRIN, BACTRIM DS, VALACYCLOVIR, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5085972-7
Mabthera side effect was reported by a Physician from BELGIUM on Aug 09, 2006. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, febrile neutropenia, haemolytic anaemia, histiocytosis haematophagic, platelet count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ALLOPURINOL, ARANESP. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5090703-0
Mabthera side effect was reported by a Physician from BELGIUM on Aug 16, 2006. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, cough, decreased appetite, diarrhoea, fatigue, febrile neutropenia, haemolytic anaemia. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ALLOPURINOL, ARANESP, NEUPOGEN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4791813-5
Mabthera side effect was reported by a Physician from BELGIUM on Sept 22, 2005. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood urea increased, febrile neutropenia, haemolytic anaemia, histiocytosis haematophagic, platelet count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ALLOPURINOL, ARANESP. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5015849-4
Mabthera side effect was reported by a Physician from BELGIUM on May 20, 2006. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood urea increased, febrile neutropenia, haemolytic anaemia, histiocytosis haematophagic, platelet count decreased, white blood cell count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ALLPURINOL, ARANESP, FLUDARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4681998-3
Mabthera side effect was reported by a Physician from on May 18, 2005. Male patient, 72 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ENOXAPARIN, SIMVASTTIN, ALLOPURINOL, ACETYLCYSTEIN, CARVEDILOL, ACEMIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4716478-X
Mabthera side effect was reported by a Physician from AUSTRIA on July 05, 2005. Male patient, 72 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mabthera dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ENOXAPARIN, SIMVASTATIN, ALLOPURINOL, ACETYLCYSTEINE, CARVEDILOL, ACEMIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4724261-4
Mabthera side effect was reported by a Health Professional from AUSTRIA on July 18, 2005. Male patient, 72 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ENOXAPARIN, SIMVASTATIN, ALLOPURINOL, ACETYLCYSTEINE, CARVEDILOL, ACEMIN. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #5071716-1
Mabthera side effect was reported by a Physician from FRANCE on July 21, 2006. Female patient, 68 years of age, weighting 158.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 820 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4745704-6
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 01, 2005. Male patient, 64 years of age, weighting 159.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atelectasis, febrile neutropenia, haemoglobin decreased, platelet count decreased, pleural effusion, pleural fibrosis, red blood cell count decreased, sepsis . Mabthera dosage: 713 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BACTRIM, ACYCLOVIR, BLOOD PRODUCTS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4774994-9
Mabthera side effect was reported by a Physician from GERMANY on Sept 09, 2005. Male patient, 64 years of age, weighting 159.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atelectasis, body temperature increased, chills, febrile neutropenia, haemoglobin decreased, lung infiltration, platelet count decreased. Mabthera dosage: 713 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BACTRIM, ACYCLOVIR, BLOOD PRODUCTS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4865822-1
Mabthera side effect was reported by a Physician from FRANCE on Dec 08, 2005. Male patient, 59 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG, UNK; INTRAVENOUS. During the same period patient was treated with ADRIABLASTINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4905309-0
Mabthera side effect was reported by a Physician from CZECH REPUBLIC on Jan 23, 2006. Female patient, 56 years of age, weighting 207.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anorectal disorder, dialysis , febrile neutropenia, granulocytopenia, multi-organ failure, nausea , pathogen resistance, pseudomonas infection, renal failure. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 01/21/2006.

Mabthera Side Effects Report #4912763-7
Mabthera side effect was reported by a Physician from CZECH REPUBLIC on Jan 30, 2006. Female patient, 56 years of age, weighting 207.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anorectal disorder, atrial fibrillation , dialysis , febrile neutropenia, granulocytopenia, hepatic failure, multi-organ failure, nausea , pathogen resistance. Mabthera dosage: 1045 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 01/21/2006.

Mabthera Side Effects Report #4912763-7
Mabthera side effect was reported by a Physician from CZECH REPUBLIC on Jan 30, 2006. Female patient, 56 years of age, weighting 207.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anorectal disorder, atrial fibrillation , dialysis , febrile neutropenia, granulocytopenia, hepatic failure, multi-organ failure, nausea , pathogen resistance. Mabthera dosage: 1045 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 01/21/2006.

Mabthera Side Effects Report #5084871-4
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 04, 2006. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: diarrhoea, electrocardiogram t wave inversion, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphadenopathy, white blood cell count decreased. Mabthera dosage: 375MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4744279-5
Mabthera side effect was reported by a Physician from GERMANY on July 27, 2005. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, diarrhoea, febrile neutropenia, laboratory test abnormal. Mabthera dosage: 500 MG, DAY 1-3, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4757152-3
Mabthera side effect was reported by a Physician from GERMANY on Aug 15, 2005. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: diarrhoea, electrocardiogram t wave inversion, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphadenopathy. Mabthera dosage: 375MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4801537-3
Mabthera side effect was reported by a Physician from BELGIUM on Oct 03, 2005. Male patient, 52 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, rash morbilliform, white blood cell count decreased. Mabthera dosage: 975 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4866624-2
Mabthera side effect was reported by a Health Professional from BELGIUM on Dec 12, 2005. Male patient, 52 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood immunoglobulin a decreased, febrile neutropenia, infection , rash morbilliform. Mabthera dosage: 975 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4921146-5
Mabthera side effect was reported by a Physician from BELGIUM on Feb 10, 2006. Male patient, 52 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 975 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4766404-2
Mabthera side effect was reported by a Physician from GERMANY on Aug 31, 2005. Male patient, 50 years of age, weighting 168.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, leukopenia. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, URALYT, ALLOPURINOL, COTRIMTE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5756173-1
Mabthera side effect was reported by a Physician from UNITED KINGDOM on May 15, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, anal fistula, febrile neutropenia, gastric ulcer, leukopenia, pain , pyrexia. Mabthera dosage: 50 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, ACETAMINOPHEN. Patient recovered.

Mabthera Side Effects Report #4685143-X
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, weighting 168.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, URALYT. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4749186-X
Mabthera side effect was reported by a Health Professional from ISRAEL on Feb 24, 2005. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, parotitis, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #4759272-6
Mabthera side effect was reported by a Health Professional from ISRAEL on Aug 23, 2005. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, parotitis. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #5803604-4
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 23, 2008. Female patient was diagnosed with castleman's disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, kaposi's sarcoma . Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died on 10/13/2005.

Mabthera Side Effects Report #5912884-6
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Sept 23, 2008. Female patient, 67 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, lymphadenopathy. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, NEUPOGEN, ATENOLOL, LOSARTAN, ANTIDIABETICS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4685189-1
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4685239-2
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4710582-8
Mabthera side effect was reported by a Health Professional from NEW ZEALAND on July 01, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count abnormal, white blood cell count abnormal. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4710621-4
Mabthera side effect was reported by a Physician from NEW ZEALAND on July 01, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816221-X
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816222-1
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 700 MG. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4923919-1
Mabthera side effect was reported by a Consumer or non-health professional from AUSTRALIA on Feb 06, 2006. Male patient, 59 years of age, weighting 187.4 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: biliary dilatation, blood urea increased, cholecystitis, cholelithiasis, febrile neutropenia, haemoglobin decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4916713-9
Mabthera side effect was reported by a Physician from AUSTRALIA on Feb 06, 2006. Female patient, 58 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mabthera dosage: 727.5 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5211799-9
Mabthera side effect was reported by a Physician from FRANCE on Jan 04, 2007. Female patient, 57 years of age, weighting 110.2 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, febrile neutropenia, pulmonary fibrosis . Mabthera dosage: unknown. During the same period patient was treated with BLEOMYCIN, NEUPOGEN, METHOTREXATE, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINDESINE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #5211799-9
Mabthera side effect was reported by a Physician from FRANCE on Jan 04, 2007. Female patient, 57 years of age, weighting 110.2 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, febrile neutropenia, pulmonary fibrosis . Mabthera dosage: unknown. During the same period patient was treated with BLEOMYCIN, GRANOCYTE, METHOTREXATE, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINDESINE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #5170310-1
Mabthera side effect was reported by a Physician from FRANCE on Nov 29, 2006. Female patient, 50 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, febrile neutropenia, interstitial lung disease, pulmonary fibrosis . Mabthera dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINDESINE, BLEOMYCIN, PREDNISONE. Patient was hospitalized. Patient recovered.